ConvaTec Group PLC banner

ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 252.6032 GBX 0.8% Market Closed
Market Cap: £4.9B

Gross Margin

55.9%
Current
Declining
by 0.2%
vs 3-y average of 56.1%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
55.9%
=
Gross Profit
$1.3B
/
Revenue
$2.4B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
55.9%
=
Gross Profit
GBX1.3B
/
Revenue
$2.4B

Peer Comparison

Country Company Market Cap Gross
Margin
UK
ConvaTec Group PLC
LSE:CTEC
5.2B GBP
Loading...
US
Medline Inc
NASDAQ:MDLN
65.7B USD
Loading...
JP
Hoya Corp
TSE:7741
9.8T JPY
Loading...
CH
Alcon AG
SIX:ALC
32B CHF
Loading...
DK
Coloplast A/S
CSE:COLO B
108.9B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.6B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.1B CNY
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
865B JPY
Loading...
US
Lantheus Holdings Inc
NASDAQ:LNTH
5B USD
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.7B USD
Loading...

Market Distribution

Higher than 97% of companies in United Kingdom
Percentile
97th
Based on 3 001 companies
97th percentile
55.9%
Low
-1 510% — 0.4%
Typical Range
0.4% — 0.7%
High
0.7% — 7 323.1%
Distribution Statistics
United Kingdom
Min -1 510%
30th Percentile 0.4%
Median 0.5%
70th Percentile 0.7%
Max 7 323.1%

ConvaTec Group PLC
Glance View

Market Cap
4.9B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
188.3268 GBX
Overvaluation 25%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
55.9%
=
Gross Profit
$1.3B
/
Revenue
$2.4B
What is ConvaTec Group PLC's current Gross Margin?

The current Gross Margin for ConvaTec Group PLC is 55.9%, which is below its 3-year median of 56.1%.

How has Gross Margin changed over time?

Over the last 3 years, ConvaTec Group PLC’s Gross Margin has increased from 54.1% to 55.9%. During this period, it reached a low of 54.1% on Jun 30, 2022 and a high of 57.1% on Dec 31, 2023.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett